Evidence map›Paper›PMID 26113434›Full record

ReviewCurrent opinion in immunology2015

TB vaccines; promoting rapid and durable protection in the lung.

Peter Andersen, Kevin B Urdahl

Open access · greenAbstract readReview
In one paragraph

Review in Current opinion in immunology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
4.9field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 40 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Antigen-experienced airway CD8Science advances · 2026
    Article
  4. Article
  5. Article
  6. Article
  7. The combination ofFrontiers in immunology · 2024
    Article
  8. Article
  9. Tools to Alleviate the Drug Resistance inMolecules (Basel, Switzerland) · 2022
    Review
  10. TOLLIP Optimizes Dendritic Cell Maturation to Lipopolysaccharide andJournal of immunology (Baltimore, Md. : 1950) · 2022
    Article
  11. Article
  12. Journal of immunology (Baltimore, Md. : 1950) · 2019
    Article
  13. Article
  14. Article
  15. Enhanced Anti-Vaccines · 2018
    Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 2 countries.

Peter AndersenStatens Serum Institut, Infectious Disease Immunology, 5 Artillerivej, DK-2300 Copenhagen S, Denmark. Electronic address: pa@ssi.dk.
Kevin B UrdahlCenter for Infectious Disease Research (Formerly Seattle Biomedical Research Institute), Seattle, WA 98109, USA; Department of Immunology, University of Washington, Seattle, WA 98109, USA.
Center for Infectious Disease Research · USStatens Serum Institut · DK

Funding

Technology CoreU19AI106761 · NIAID · SEATTLE BIOMEDICAL RESEARCH INSTITUTE · PI SHERMAN, DAVID R, ZAK, DANIEL E · 2013 to 2017
$18.9M
T regulatory cells and immunity in tuberculosisR01AI076327 · NIAID · UNIVERSITY OF WASHINGTON · PI URDAHL, KEVIN B · 2009 to 2018
$4.5M
NIAID NIH HHS R01 AI076327NIAID NIH HHS U19 AI106761
6 · The paper itself

Abstract

TB vaccine discovery has focused on IFN-γ both for the selection of antigens and vaccine delivery strategies. Recent breakthroughs in our understanding of the requirements for immunological memory and the expression of immunity to TB in the lung now provide a framework for reconsidering that strategy. We will discuss the status of the TB vaccine field, recent insights into the role of central memory cells and the potential of tissue-resident memory cells in vaccine promoted protection against TB.

Indexed as

AnimalsClinical Trials as TopicHumansImmunologic MemoryInterferon-gammaLungMycobacterium tuberculosisT-LymphocytesTuberculosisVaccinesInterferon-gammaVaccines

Identifiers

PMID26113434
PMCPMC4641675
OpenAlexW759014506

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.